flunixin meglumine has been researched along with Escherichia coli Infections in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gehrke, M; Krumrych, W; Markiewicz, H | 1 |
| Leslie, KE; McGilliard, ML; Petersson-Wolfe, CS; Yeiser, EE | 1 |
| Badiei, K; Chalmeh, A; Nazifi, S; Pourjafar, M | 1 |
| Luby, CD; Middleton, JR | 1 |
| Hardie, EM; Kolata, RJ; Rawlings, CA | 1 |
| Booker, CA; Chiffelle, CL; Dascanio, JJ; Gröhn, YT; Kenney, DG; Mechor, GD; Musser, JM; Thompson, P; Warnick, LD | 1 |
| Anders, B; Barton, MH; Baskett, A; Moore, JN; Norton, N | 1 |
| Eklund, K; Hirvonen, J; Huszenicza, G; Kulcsar, M; Pyörälä, S; Saloniemi, H; Teppo, AM | 1 |
| Anderson, KL; Davis, BJ; Hunt, E | 1 |
| Brand, A; Lohuis, JA; Van Leeuwen, W; Van Miert, AS; Verheijden, JH | 1 |
| Anderson, KL; Hunt, E | 1 |
| Bottoms, GD; Denicola, DB; Reed, WM; Stegelmeier, BL | 1 |
| Hardie, EM; Rakich, PM; Rawlings, CA; Shotts, EB; Waltman, DW | 1 |
2 trial(s) available for flunixin meglumine and Escherichia coli Infections
| Article | Year |
|---|---|
The effect of supportive E. coli mastitis treatment on PMN chemiluminescence and subpopulations of T lymphocytes.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Cattle; Clonixin; Escherichia coli Infections; Female; Luminescence; Mastitis, Bovine; Muramidase; Neutrophils; T-Lymphocyte Subsets | 2013 |
Effect of phenylbutazone and flunixin meglumine on acute toxic mastitis in dairy cows.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Appetite; Bacteria; Body Temperature; Cattle; Clonixin; Double-Blind Method; Escherichia coli; Escherichia coli Infections; Female; Gastrointestinal Motility; Gentamicins; Heart Rate; Infusions, Parenteral; Klebsiella; Klebsiella Infections; Lactation; Mastitis, Bovine; Milk; Phenylbutazone; Respiration; Rumen | 1995 |
11 other study(ies) available for flunixin meglumine and Escherichia coli Infections
| Article | Year |
|---|---|
The effects of experimentally induced Escherichia coli mastitis and flunixin meglumine administration on activity measures, feed intake, and milk parameters.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Clonixin; Eating; Escherichia coli Infections; Female; Lactation; Mastitis, Bovine; Motor Activity | 2012 |
Anti-inflammatory effects of insulin regular and flunixin meglumine on endotoxemia experimentally induced by Escherichia coli serotype O55:B5 in an ovine model.
Topics: Animals; Anti-Inflammatory Agents; Clonixin; Disease Models, Animal; Endotoxemia; Escherichia coli Infections; Female; Glutathione Peroxidase; Haptoglobins; Insulin; Interferon-gamma; Serum Amyloid A Protein; Sheep; Tumor Necrosis Factor-alpha | 2013 |
Escherichia coli mastitis in cattle being treated for Staphylococcus aureus intramammary infection.
Topics: Animals; Anti-Bacterial Agents; Cattle; Clindamycin; Clonixin; Escherichia coli; Escherichia coli Infections; Female; Mastitis, Bovine; Milk; Prostaglandin Antagonists; Retrospective Studies; Risk Factors; Staphylococcal Infections | 2008 |
Canine septic peritonitis: treatment with flunixin meglumine.
Topics: Animals; Blood Cell Count; Blood Glucose; Clonixin; Cyclooxygenase Inhibitors; Dogs; Escherichia coli Infections; Hemodynamics; Nicotinic Acids; Peritonitis; Respiration | 1983 |
Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses.
Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature; Clonixin; Disease Models, Animal; Drug Combinations; Endotoxemia; Escherichia coli; Escherichia coli Infections; Hemodynamics; Horse Diseases; Horses; Interleukin-6; Leukocyte Count; Pentoxifylline; Plasminogen Activator Inhibitor 1; Thromboxane B2; Time Factors; Tissue Plasminogen Activator; Tumor Necrosis Factor-alpha; Vasodilator Agents | 1997 |
Acute phase response in dairy cows with experimentally induced Escherichia coli mastitis.
Topics: Acute-Phase Reaction; Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Clonixin; Colony Count, Microbial; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Haptoglobins; Hydrocortisone; Mastitis, Bovine; Milk; Nitrites; Quinolones; Random Allocation; Serum Amyloid A Protein; Tumor Necrosis Factor-alpha | 1999 |
The influence of anti-inflammatory therapy on bacterial clearance following intramammary Escherichia coli challenge in goats.
Topics: Animals; Body Temperature; Cattle; Clonixin; Colony Count, Microbial; Dexamethasone; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Goats; Lactation; Leukocyte Count; Lymph Nodes; Mammary Glands, Animal; Mastitis, Bovine; Milk; Random Allocation; Shock, Septic | 1991 |
Flunixin meglumine and flurbiprofen in cows with experimental Escherichia coli mastitis.
Topics: Animals; Body Temperature; Cattle; Clonixin; Escherichia coli Infections; Female; Flurbiprofen; Heart Rate; Mastitis, Bovine; Muscle Contraction; Muscle, Smooth; Nicotinic Acids; Propionates; Rumen | 1989 |
Anti-inflammatory therapy in acute endotoxin-induced bovine mastitis.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Clonixin; Dexamethasone; Escherichia coli; Escherichia coli Infections; Female; Lactation; Leukocyte Count; Lipopolysaccharides; Mastitis, Bovine; Nicotinic Acids; Pregnancy | 1989 |
Effects of flunixin meglumine in dogs following experimentally induced endotoxemia.
Topics: Animals; Clonixin; Dog Diseases; Dogs; Endotoxins; Escherichia coli; Escherichia coli Infections; Female; Male; Nicotinic Acids; Random Allocation; Shock, Septic | 1988 |
Escherichia coli-induced lung and liver dysfunction in dogs: effects of flunixin meglumine treatment.
Topics: Animals; Clonixin; Dog Diseases; Dogs; Escherichia coli Infections; Hemodynamics; Liver Diseases; Lung Diseases; Nicotinic Acids | 1987 |